Shareholders Equity: The sum of preferred and common equity items.
vTv Therapeutics Inc. (VTVT) had Shareholders Equity of $64.44M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-26.97M |
|
-- |
|
-- |
|
$32.81M |
|
$-32.81M |
|
$1.73M |
|
$-31.08M |
|
$-31.08M |
|
$-31.08M |
|
$-31.08M |
|
$-31.08M |
|
$-31.08M |
|
$-32.81M |
|
$-32.79M |
|
8.42M |
|
8.42M |
|
$-3.20 |
|
$-3.20 |
|
| Balance Sheet Financials | |
$89.89M |
|
-- |
|
$0.01M |
|
$89.90M |
|
$6.64M |
|
-- |
|
$18.82M |
|
$25.46M |
|
$64.44M |
|
$64.44M |
|
|
Shareholders Equity |
$64.44M |
3.94M |
|
| Cash Flow Statement Financials | |
$-25.25M |
|
-- |
|
$77.44M |
|
$36.75M |
|
$88.93M |
|
$52.19M |
|
$3.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-48.23% |
|
-48.23% |
|
-34.57% |
|
-48.23% |
|
$16.36 |
|
$-3.00 |
|
$-3.00 |
|